Cargando…
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
Cytarabine (AraC) is an essential chemotherapeutic for acute myeloid leukemia (AML) and resistance to this drug is a major cause of treatment failure. AraC is a nucleoside analog that differs from 2′-deoxycytidine only by the presence of an additional hydroxyl group at the C2′ position of the 2′-deo...
Autores principales: | Rechkoblit, Olga, Choudhury, Jayati Roy, Buku, Angeliki, Prakash, Louise, Prakash, Satya, Aggarwal, Aneel K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107656/ https://www.ncbi.nlm.nih.gov/pubmed/30140014 http://dx.doi.org/10.1038/s41598-018-30796-w |
Ejemplares similares
-
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η
por: Rechkoblit, Olga, et al.
Publicado: (2019) -
Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy
por: Ummat, Ajay, et al.
Publicado: (2012) -
Mechanism of error-free DNA synthesis across N1-methyl-deoxyadenosine by human DNA polymerase-ι
por: Jain, Rinku, et al.
Publicado: (2017) -
Structural basis of DNA synthesis opposite 8-oxoguanine by human PrimPol primase-polymerase
por: Rechkoblit, Olga, et al.
Publicado: (2021) -
Crystal Structure of Yeast DNA Polymerase ε Catalytic Domain
por: Jain, Rinku, et al.
Publicado: (2014)